A drug which is said to "reboot" the immune system has been shown to be an effective treatment for multiple sclerosis (MS), a study has found.
The results of the trials were so encouraging in reducing the number of attacks in those affected that the MS Society is campaigning for the drug to become available on the NHS.
The research showed that alemtuzumab significantly reduced the number of attacks or relapses by people with MS compared to the current drug interferon beta-1a which is known commercially as Rebif.
More top news
Migrants desperate to reach Britain from Calais have told how making the dangerous journey is their "last chance".
Malaysian Airlines flight MH370 vanished more than a year ago carrying 239 people on board. Here is a look at the key events since.
Investigators have released images of two more people they wish to speak to about the Hillsborough tragedy.